Guidelines for Managing Hyperlipidemia

Risk Assessment

The American College of Cardiology recommends evaluating total cardiovascular risk before initiating treatment, considering factors such as age, family history, hypertension, diabetes, and existing cardiovascular disease 1
Obtain a complete lipid profile (total cholesterol, LDL-C, HDL-C, triglycerides) for risk assessment 1
Screen men aged 20-35 years and women aged 20-45 years with risk factors including diabetes, family history of premature cardiovascular disease, familial hyperlipidemia, or multiple coronary heart disease risk factors 2
For adults without risk factors, screening can begin at age 40 for men and age 50 for women or post-menopause 3
Consider more frequent screening for individuals with lipid levels close to treatment thresholds and less frequent for those with consistently normal levels 2

Implement lifestyle modifications in all patients as first-line therapy and as synergistic means for improving lipid control 1
Recommend a diet low in saturated fat (7-10% of calories) and high in fruits and vegetables 2
Consider plant-based diet and limiting red meat consumption 1
Encourage consumption of foods rich in omega-3 polyunsaturated fats (fish, nuts, flaxseed oil) 1
Consider foods enriched with phytosterols (1-2 g/day) for individuals with elevated total and LDL cholesterol 1

Start with statins as first-line pharmacological therapy for persistent hyperlipidemia 1
Align statin dosage intensity to ASCVD risk 1
Monitor lipid levels 4-12 weeks after starting treatment or dose adjustment 1
Check liver enzymes (ALT) before treatment and 8-12 weeks after starting therapy or dose increase 1
Monitor creatine kinase (CK) before starting therapy and be alert for myopathy symptoms 1
Consider non-statin therapy in patients who cannot tolerate statins or fail to achieve LDL-C goals despite maximally tolerated statin dose 1
Options include bile acid sequestrants, fibrates, ezetimibe, PCSK9 inhibitors, and nicotinic acid 1
For severe hypertriglyceridemia (>500 mg/dL), consider fibrates such as gemfibrozil (600 mg twice daily) or fenofibrate (54-160 mg daily) 1

Consider statins in children aged >8 years with concerning family history or extremely elevated LDL-C or Lp(a) 1
Start with lifestyle modifications as first-line treatment for hyperlipidemia in children 1

Base treatment goals on individual cardiovascular risk assessment 1
Regularly assess adherence to lifestyle changes and effects of LDL-C lowering medication 1

Check lipid levels 8 (±4) weeks after starting treatment or adjusting dose 1
Monitor for common side effects, including myopathy and elevated liver enzymes 1